Blue benzoquinone from scorpion venom shows bactericidal activity against drug-resistant strains of the priority pathogen Acinetobacter baumannii

Ramsés Gallegos‐Monterrosa, Jimena I. Cid-Uribe, Gustavo Delgado-Prudencio, Deyanira Pérez‐Morales, María M. Banda, Alexis Téllez-Galván, Edson Norberto Carcamo-Noriega, Ulises Garza–Ramos, Richard N. Zare, Lourival Domingos Possani, Vı́ctor H. Bustamante · 2025

Read Blue benzoquinone from scorpion venom shows bactericidal activity against drug-resistant strains of the priority pathogen Acinetobacter baumannii by Ramsés Gallegos‐Monterrosa, Jimena I. Cid-Uribe, Gustavo Delgado-Prudencio, Deyanira Pérez‐Morales, María M. Banda, Alexis Téllez-Galván, Edson Norberto Carcamo-Noriega, Ulises Garza–Ramos, Richard N. Zare, Lourival Domingos Possani, Vı́ctor H. Bustamante (2025) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/openalex-w4407676845.txt.

Description

Ramsés Gallegos-Monterrosa, Jimena Cid-Uribe, Gustavo Delgado-Prudencio, and colleagues test a scorpion venom compound against drug-resistant bacteria. Their paper appeared in The Journal of Antibiotics in 2025. The blue benzoquinone comes from the Mexican scorpion Diplocentrus melici. Earlier work showed it kills staph and tuberculosis germs.

Here the compound killed clinical strains of a priority hospital pathogen, Acinetobacter baumannii. It worked even on strains resistant to last-resort drugs such as carbapenem and colistin. The germs never learned to resist it, even after many growth cycles at low doses, unlike with standard drugs. A cheap synthetic route already exists. The results make the compound a strong lead for a new antibiotic class.

Catalog record

CREATORRamsés Gallegos‐Monterrosa, Jimena I. Cid-Uribe, Gustavo Delgado-Prudencio, Deyanira Pérez‐Morales, María M. Banda, Alexis Téllez-Galván, Edson Norberto Carcamo-Noriega, Ulises Garza–Ramos, Richard N. Zare, Lourival Domingos Possani, Vı́ctor H. Bustamante
YEAR2025
COLLECTIONPAPERS
FORMATTXT
FILE SIZE47 KB
LICENSECC BY 4.0
RIGHTSCC BY
SOURCEOpenAlex / The Journal of Antibiotics

Source: https://doi.org/10.1038/s41429-025-00809-8

Browse the full library · About the Tower of Babel